HAE-话题@MedSci

#HAE#

411篇内容 | 2298人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2008444, encodeId=39a1200844463, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：产前治疗or产后治疗，霍奇金淋巴瘤孕妇患者及新生儿的生存预后有什么不同？, objectType=article, longId=182768, objectId=5572182e688d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5572182e688d, replyNumber=0, likeNumber=80, createdTime=2020-01-25, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5572182e688d, moduleTitle=Lancet Haematol：产前治疗or产后治疗，霍奇金淋巴瘤孕妇患者及新生儿的生存预后有什么不同？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5572182e688d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008461, encodeId=88dc20084614a, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haematol：Enasidenib治疗IDH2突变型骨髓增生异常综合征, objectType=article, longId=189592, objectId=c3fe18959242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3fe18959242, replyNumber=0, likeNumber=75, createdTime=2020-03-31, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3fe18959242, moduleTitle=Lancet haematol：Enasidenib治疗IDH2突变型骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3fe18959242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008474, encodeId=ab3f20084e4c7, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：抗凝治疗的房颤患者白细胞介素-6与死亡风险, objectType=article, longId=195696, objectId=3502195696ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3502195696ff, replyNumber=0, likeNumber=80, createdTime=2021-01-24, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3502195696ff, moduleTitle=J Thromb Haemost：抗凝治疗的房颤患者白细胞介素-6与死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3502195696ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008442, encodeId=6cb5200844236, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haemat：如何评估肥大细胞增多症患者的预后？, objectType=article, longId=182244, objectId=6b5518224444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b5518224444, replyNumber=0, likeNumber=92, createdTime=2020-10-16, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b5518224444, moduleTitle=Lancet haemat：如何评估肥大细胞增多症患者的预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b5518224444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008453, encodeId=d9fd2008453af, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：5种一线晚期霍奇金淋巴瘤治疗方案成本效益评估, objectType=article, longId=186274, objectId=72631862e452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72631862e452, replyNumber=0, likeNumber=89, createdTime=2020-09-10, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72631862e452, moduleTitle=Lancet Haematol：5种一线晚期霍奇金淋巴瘤治疗方案成本效益评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72631862e452)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008481, encodeId=10ac2008481e9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haematol：感染COVID-19的血液恶性肿瘤患者的临床特征和不良预后相关因素, objectType=article, longId=199489, objectId=05571994897d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05571994897d, replyNumber=0, likeNumber=56, createdTime=2021-05-31, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05571994897d, moduleTitle=Lancet haematol：感染COVID-19的血液恶性肿瘤患者的临床特征和不良预后相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05571994897d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008447, encodeId=d617200844e3e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=TAKHZYRO（lanadelumab注射液）获得加拿大药物专家委员会的积极推荐，用于常规预防遗传性血管性水肿（HAE）发作, objectType=article, longId=183553, objectId=65371835530b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65371835530b, replyNumber=0, likeNumber=66, createdTime=2020-03-22, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65371835530b, moduleTitle=TAKHZYRO（lanadelumab注射液）获得加拿大药物专家委员会的积极推荐，用于常规预防遗传性血管性水肿（HAE）发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65371835530b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008437, encodeId=67f5200843e15, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haemat：全膝关节置换的患者预防静脉血栓栓塞的更佳措施, objectType=article, longId=178323, objectId=cde01e8323a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cde01e8323a1, replyNumber=0, likeNumber=72, createdTime=2020-07-04, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cde01e8323a1, moduleTitle=Lancet haemat：全膝关节置换的患者预防静脉血栓栓塞的更佳措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cde01e8323a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008472, encodeId=f31c20084e21f, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：COVID-19患者静脉血栓栓塞发生率 , objectType=article, longId=193753, objectId=be72193e5341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be72193e5341, replyNumber=0, likeNumber=42, createdTime=2021-04-01, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be72193e5341, moduleTitle=J Thromb Haemost：COVID-19患者静脉血栓栓塞发生率 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be72193e5341)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008455, encodeId=69bf2008455fa, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haematol：硼替佐米治疗特发性多中心Castleman病的长期安全性, objectType=article, longId=187424, objectId=563618e4243b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=563618e4243b, replyNumber=0, likeNumber=85, createdTime=2020-07-28, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=563618e4243b, moduleTitle=Lancet haematol：硼替佐米治疗特发性多中心Castleman病的长期安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=563618e4243b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008463, encodeId=fe122008463d6, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：抗磷脂综合征以及实验室检查阳性与NBTE患病率的关系 , objectType=article, longId=190231, objectId=f5bf19023104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5bf19023104, replyNumber=0, likeNumber=50, createdTime=2021-01-26, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5bf19023104, moduleTitle=J Thromb Haemost：抗磷脂综合征以及实验室检查阳性与NBTE患病率的关系 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5bf19023104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008469, encodeId=37b6200846959, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, objectType=article, longId=192943, objectId=28a119294391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28a119294391, replyNumber=0, likeNumber=66, createdTime=2020-04-29, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28a119294391, moduleTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28a119294391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008456, encodeId=662320084560b, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！, objectType=article, longId=187425, objectId=b82918e4252e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b82918e4252e, replyNumber=0, likeNumber=75, createdTime=2020-10-20, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b82918e4252e, moduleTitle=Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b82918e4252e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008439, encodeId=4daf2008439d5, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理, objectType=article, longId=180921, objectId=5b5618092125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b5618092125, replyNumber=0, likeNumber=95, createdTime=2019-11-02, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b5618092125, moduleTitle=Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b5618092125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008460, encodeId=b4f4200846019, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haematol：遗传性I型抗凝血酶缺乏症女性发生妊娠相关静脉血栓栓塞和产科并发症的风险, objectType=article, longId=189140, objectId=5f6a189140d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f6a189140d8, replyNumber=0, likeNumber=54, createdTime=2020-03-12, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f6a189140d8, moduleTitle=Lancet haematol：遗传性I型抗凝血酶缺乏症女性发生妊娠相关静脉血栓栓塞和产科并发症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f6a189140d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008458, encodeId=29912008458a9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：新型冠状病毒性肺炎患者的凝血参数异常与预后不良有关, objectType=article, longId=188460, objectId=d6b91884601a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6b91884601a, replyNumber=0, likeNumber=69, createdTime=2020-03-28, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6b91884601a, moduleTitle=J Thromb Haemost：新型冠状病毒性肺炎患者的凝血参数异常与预后不良有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6b91884601a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008451, encodeId=4843200845131, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haemat：Shwachman-Diamond综合征合并MDS或AML患者的临床特征及预后, objectType=article, longId=185331, objectId=f042185331ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f042185331ad, replyNumber=0, likeNumber=0, createdTime=2020-03-08, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f042185331ad, moduleTitle=Lancet Haemat：Shwachman-Diamond综合征合并MDS或AML患者的临床特征及预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f042185331ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008448, encodeId=f08920084485d, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haemat：超声加速导管溶栓预防血栓后综合征, objectType=article, longId=184623, objectId=16c518462376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16c518462376, replyNumber=0, likeNumber=57, createdTime=2020-06-01, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16c518462376, moduleTitle=Lancet Haemat：超声加速导管溶栓预防血栓后综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16c518462376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008432, encodeId=f693200843297, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：高血小板计数和高血细胞比容与动静脉血栓形成的关系, objectType=article, longId=175698, objectId=42861e5698fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42861e5698fa, replyNumber=0, likeNumber=54, createdTime=2020-02-04, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42861e5698fa, moduleTitle=J Thromb Haemost：高血小板计数和高血细胞比容与动静脉血栓形成的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42861e5698fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008449, encodeId=389c2008449ce, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haemat：极光激酶A抑制剂alisertib治疗高危型急性粒细胞白血病, objectType=article, longId=184769, objectId=59fd184e6932, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59fd184e6932, replyNumber=0, likeNumber=62, createdTime=2020-03-18, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59fd184e6932, moduleTitle=Lancet Haemat：极光激酶A抑制剂alisertib治疗高危型急性粒细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59fd184e6932)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HAE

2020-05-29

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：产前治疗or产后治疗，霍奇金淋巴瘤孕妇患者及新生儿的生存预后有什么不同？

2020-01-25

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haematol：Enasidenib治疗IDH2突变型骨髓增生异常综合征

2020-03-31

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：抗凝治疗的房颤患者白细胞介素-6与死亡风险

2021-01-24

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haemat：如何评估肥大细胞增多症患者的预后？

2020-10-16

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：5种一线晚期霍奇金淋巴瘤治疗方案成本效益评估

2020-09-10

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haematol：感染COVID-19的血液恶性肿瘤患者的临床特征和不良预后相关因素

2021-05-31

changfy (审核中...)

前往app查看评论内容

#HAE#

TAKHZYRO（lanadelumab注射液）获得加拿大药物专家委员会的积极推荐，用于常规预防遗传性血管性水肿（HAE）发作

2020-03-22

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haemat：全膝关节置换的患者预防静脉血栓栓塞的更佳措施

2020-07-04

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：COVID-19患者静脉血栓栓塞发生率

2021-04-01

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haematol：硼替佐米治疗特发性多中心Castleman病的长期安全性

2020-07-28

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：抗磷脂综合征以及实验室检查阳性与NBTE患病率的关系

2021-01-26

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比

2020-04-29

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！

2020-10-20

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理

2019-11-02

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haematol：遗传性I型抗凝血酶缺乏症女性发生妊娠相关静脉血栓栓塞和产科并发症的风险

2020-03-12

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：新型冠状病毒性肺炎患者的凝血参数异常与预后不良有关

2020-03-28

医者仁心 (审核中...)

前往app查看评论内容

#HAE#

Lancet Haemat：Shwachman-Diamond综合征合并MDS或AML患者的临床特征及预后

2020-03-08

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haemat：超声加速导管溶栓预防血栓后综合征

2020-06-01

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：高血小板计数和高血细胞比容与动静脉血栓形成的关系

2020-02-04

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haemat：极光激酶A抑制剂alisertib治疗高危型急性粒细胞白血病

2020-03-18

科室
- - 订阅+
  - 更多科室
工具
服务